John R. Stuelpnagel, Director at 10x Genomics, Inc. (TXG), sold 20,000 shares at $60.66 ($1.2M) on 2026-09-03, disclosed to the SEC on 2026-09-08.
Seasonal sale ($1.2M) by Director — this insider has traded TXG in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.66 | 7,012 | $425K | 34.4% |
| 2 | $62.11 | 6,814 | $423K | 34.3% |
| 3 | $62.61 | 6,174 | $387K | 31.3% |
| Total | $61.75 avg | 20,000 | $1.2M | 100% |
| Filing → |
| TXG | SELL | 2022-01-04 | $1.5M | — | Filing → |
| TXG | SELL | 2021-12-03 | $756K | — | Filing → |
| TXG | SELL | 2021-11-18 | $1.6M | — | Filing → |